For example, it has been revealed that apoc1 may induce glomerulosclerosis (GS) by enhancing the cytokine response of macrophages, suggesting that apoc1 can serve as a promising new therapeutic target in GS [7]. This evidence concerns the gene APOC1 and glomerulosclerosis.